Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://journals.lww.com/amjclinicaloncology/abstract/2008/12000/histopathological_response_to_preoperative.4.aspx, but it redirected us to https://journals.lww.com/amjclinicaloncology/abstract/2008/12000/histopathological_response_to_preoperative.4.aspx. The analysis below is for the second page.

Title[redir]:
American Journal of Clinical Oncology
Description:
to neoadjuvant therapy may serve as a surrogate marker for treatment efficacy and remains an active area of investigation. Objectives: The chemoradiosensitivity of pancreatic adenocarcinoma has not yet fully been assessed. The purpose of this study is to determine the efficacy of preoperative chemoradiation, measured by the impact on the R0 resection rate and the histopathological response rate in patients presenting with resectable pancreatic adenocarcinoma. Methods: Patients with localized, potentially resectable pancreatic adenocarcinoma were treated with 50 Gy irradiation combined with 5-fluorouracil by continuous infusion (300 mg · m−2 · d−1; day 1–5; week 1–5) and cisplatin (20 mg · m−2 · d−1; day 1–5 and day 29–33). Patients presenting with resectable disease at restaging, without metastatic dissemination, underwent surgical resection. Results: Forty-one patients were enrolled. Twenty-seven patients (67.5%) completed chemoradiation receiving at least 75% prescribed chemotherapy dose without grade 4 nonhematological toxicity. Twenty-six patients (63%) underwent surgical resection with curative intent and 21 (80.7%) had R0 resection. Thirteen of 26 specimens (50%) presented a major pathologic response with more than 80% of severely degenerative cancer cells. Complete pathologic response was observed in one specimen. Median survival time and 2-year survival rate were 9.4 months and 20% for the entire cohort. The local recurrence and 2-year survival rates were 4% and 32%, respectively, for the 26 operated patients. Conclusions: This study suggests that some pancreatic adenocarcinomas are chemoradiosensitive and that preoperative chemoradiation provides antitumoral effect associated with major histopathological response in 50% of patients and a high R0 resection rate. Further research is needed to determine the biologic difference between responders and nonresponders, to evaluate the predictive value of treatment response parameters, and to optimize the chemoradiation regimen....

Matching Content Categories {📚}

  • Health & Fitness
  • Non-Profit & Charity
  • Telecommunications

Content Management System {📝}

What CMS is doi.org built with?


Doi.org employs MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌍 Impressive Traffic: 500k - 1M visitors per month


Based on our best estimate, this website will receive around 600,420 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

journal, patients, response, chemoradiation, pancreatic, phd, resection, histopathological, adenocarcinoma, rate, issue, preoperative, resectable, access, log, subscribe, alerts, authors, abstract, study, major, day, survival, register, logo, articles, issues, article, american, buy, purpose, suggests, chemoradiosensitive, antitumoral, effect, high, treatment, efficacy, determine, presenting, underwent, surgical, pathologic, year, text, subscribers, request, browse, content, submit,

Topics {✒️}

journal authors submit institutional users access r0 resection rate 2-year survival rate full text access underwent surgical resection histopathological response rate median survival time 2-year survival rates artificial intelligence training major pathologic response complete pathologic response gastrointestinal histopathological response major histopathological response resectable pancreatic adenocarcinoma treatment response parameters etoc alerts pierre-jean md jean-yves md completed chemoradiation receiving service request 800-638-3030 register subscribe individual subscribers log journal tables r0 resection access log issue histopathological response pancreatic adenocarcinoma journal resectable disease website subscribe pancreatic adenocarcinomas center submit romuald md françoise md christian md† marc md pascal md preoperative chemoradiation chemoradiation regimen clinical oncology 31 antitumoral effect neoadjuvant therapy surrogate marker treatment efficacy active area continuous infusion metastatic dissemination curative intent

Questions {❓}

  • Not a Subscriber?

Social Networks {👍}(1)

External Links {🔗}(59)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Tag Manager

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Scite
  • Wolterskluwer

5.11s.